These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28166057)

  • 41. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluations of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer.
    Liu H; Wu Q
    Med Phys; 2011 Dec; 38(12):6362-70. PubMed ID: 22149819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility.
    Kirk ML; Tang S; Zhai H; Vapiwala N; Deville C; James P; Bekelman JE; Christodouleas JP; Tochner Z; Both S
    Pract Radiat Oncol; 2015; 5(2):99-105. PubMed ID: 25413411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
    Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
    Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
    Berger T; Petersen JBB; Lindegaard JC; Fokdal LU; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1472-1478. PubMed ID: 28931343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scenario-based radiation therapy margins for patient setup, organ motion, and particle range uncertainty.
    Bokrantz R; Fredriksson A
    Phys Med Biol; 2017 Feb; 62(4):1342-1357. PubMed ID: 28114114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
    Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
    Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy.
    Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
    Acta Oncol; 2017 Jun; 56(6):832-838. PubMed ID: 28281357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
    Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
    Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
    Góra J; Stock M; Lütgendorf-Caucig C; Georg D
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):881-8. PubMed ID: 22818417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.
    Zhang X; Dong L; Lee AK; Cox JD; Kuban DA; Zhu RX; Wang X; Li Y; Newhauser WD; Gillin M; Mohan R
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):620-9. PubMed ID: 17236979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of anterior proton beams in the setting of a prostate-rectum spacer.
    Christodouleas JP; Tang S; Susil RC; McNutt TR; Song DY; Bekelman J; Deville C; Vapiwala N; Deweese TL; Lu HM; Both S
    Med Dosim; 2013; 38(3):315-9. PubMed ID: 23578497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of megavoltage computed tomographic scan methodology on setup verification and adaptive dose calculation in helical TomoTherapy.
    Zhu J; Bai T; Gu J; Sun Z; Wei Y; Li B; Yin Y
    Radiat Oncol; 2018 Apr; 13(1):80. PubMed ID: 29699582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancing knowledge-based intensity modulated proton planning for adaptive treatment of high-risk prostate cancer.
    Johnson CL; Hasan S; Huang S; Lin H; Gorovets D; Shim A; Apgar T; Yu F; Tsai P
    Med Dosim; 2024 Spring; 49(1):19-24. PubMed ID: 37914563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.
    Hild S; Graeff C; Rucinski A; Zink K; Habl G; Durante M; Herfarth K; Bert C
    Strahlenther Onkol; 2016 Feb; 192(2):118-26. PubMed ID: 26614393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.